NSE: PVRINOX· MediaTurnaround · Aug 26Small cap

PVR Inox

Exhibition duopoly-of-one at book

Last close
₹1,190.10
29 Sept 2026 · reference
1D · 1M
−2.8% · −2.5%
price-only
Weight
1.5%
31 Jul 2026 · Aug rank 24
Thesis review
8 Sep 2026
Why We Own, p64
Coverage owner: Research (per book); latest results Q Jun-26Screener ↗Tijori ↗NSE ↗
What the business is

Approved description

India's largest multiplex chain (merger of PVR and INOX in 2023) with 1,798 screens across 359 cinemas in 113 cities at Mar-26 - roughly 40% of India's multiplex screens and ~18% of the country's 10,033 total screens. Revenue comes from box office (~52%), F&B (~30%), advertising and convenience fees; FY26 admissions were 150 mn at an ATP of Rs 280 and F&B spend per head Rs 147. Expansion has shifted to capital-light FOCO/asset-light formats (55% of FY26 additions) to reach zero net debt.

Why we own it · 5 approved reasons
  1. 01Volume + price + spend all growing: Q1FY27 admissions +8% (36.6 mn), ATP +8% (Rs 273), F&B SPH +9% (Rs 161) with no Rs 500 cr+ blockbuster in H1 CY26 - a weak-content quarter still doubled pre-Ind AS 116 EBITDA to Rs 230 cr.
  2. 02Balance-sheet repair nearly done: net debt ~Rs 1,100 cr (Jun-2026 est.) targeted at zero by end-FY27 via Rs 600-800 cr annual operating cash flow, ~Rs 100 cr non-core asset sales and 100% internally funded capex (FY26 capex Rs 254 cr, -24% YoY); interest savings ~Rs 150 cr/yr.
  3. 03Capital-light growth: signed pipeline of 138 screens (52 FOCO, 86 asset-light) and ~100 screen openings guided for FY27 (150-160 longer-run) on top of 1,798 screens; 55% of FY26 additions were capital-light and 44% were in South India.
  4. 04Structural under-screening: India has 6.8 screens per million vs China 64 / USA 109 and only 3,150 of 19,500 pin codes have a cinema (FICCI-EY 2026), while box office hit a record Rs 13,395 cr in CY25 and Rs 6,398 cr in H1 CY26 (+10%).
  5. 05Earnings inflection at a modest multiple: FY26 was the first profitable year post-merger (PAT Rs 333 cr vs -Rs 281 cr) and Buoyant's FY28e P/E of 21.5x is roughly half the trailing multiple.
Full thesis, sizing and review history →
Price

Reference close, with results-period markers

PVRINOX
Close as of 29 Sept 2026
  1. 1Q Sep-25 end · 30 Sept 2025
  2. 2Q Dec-25 end · 31 Dec 2025
  3. 3Q Mar-26 end · 31 Mar 2026
  4. 4Q Jun-26 end · 30 Jun 2026
Yahoo Finance chart API (unlicensed reference data; not for redistribution). Price-only series (split-adjusted; dividends excluded). Gaps are non-trading days.
1D
−2.8%
28 Sept 2026
1W
−10.8%
22 Sept 2026
1M
−2.5%
28 Aug 2026
3M
+23.8%
29 Jun 2026
6M
+26.9%
27 Mar 2026
1Y
+8.1%
29 Sept 2025
Buoyant Screener

Quality score, technicals and Buoyant Score

Value it →

Computing the scorecard…

Results centre

Latest quarter · Q Jun-26

Latest quarter versus prior year and prior quarter
Line (₹ cr)Q Jun-26YoYQoQ
Net Sales1,622+11.9%+4.8%
Operating Profit529+30.9%+17.0%
Net Profit57turned profitable−69.8%
Implication for thesisBroadly unchanged · per 8 Sep 2026 reviewQ1FY27 (Jun-26): revenue 1,622 (+11.9% YoY), PAT 57 (n.a.)

Reported vs internal estimate: internal quarterly estimates are not in the supplied package; consensus feed not licensed. YoY/QoQ per PRD §12.5 (transitions, not %, on non-positive bases).

Key facts

Position and valuation context

1.5%
Weight, 31 Jul 2026
Aug rank 24 · Turnaround
₹11,111 cr
Market cap, July 2026 research sheet
Tijori latest: 13,109 Cr
42.8x
P/E FY27E · Buoyant
FY28E 21.5x
3.9%
ROE FY27E · Buoyant
FY28E 5.4%
29.5x
P/E trailing (Tijori)
4.53%
ROE latest FY (Tijori)
ROCE 7.91%

General industrial/consumer/IT preset: growth, margins, ROCE/ROIC, working capital, FCF, net debt; P/E, EV/EBITDA.

Street view · 1 report
All broker research →
Target (median)
₹1,500
ICICI Securities
Implied vs 29 Sept 2026
+26.0%
on ₹1,190.1 reference close
Ratings
1/0/0
buy / neutral / sell · latest 27 Jul 2026

Sell-side targets are third-party views, not Buoyant's; the upside is recomputed on our reference close, so it differs from the figure printed at the broker's price date.

Investment case and valuation

Valuation range

No headline target on this page; the book quotes the thesis and the risk rather than a target.

₹1,157
Price (2026-09-07)
42.8x / 21.5x
FY27E / FY28E P/E (Buoyant sheet)
3.9%
FY27E ROE (Buoyant sheet)
35.8x
Trailing P/E
1.5x
Price / book
24%
EPS CAGR FY26–28E
Assumptions, sensitivity, scenarios →
Next catalysts · material risks

What we watch

Catalysts
  • H2 FY27 (Oct-Dec 2026) festive slate plus bunched Q2/Q3 screen openings (~100 for FY27) - Q3FY27 results in Jan-2027 are the key print.
  • Zero net debt milestone targeted by end-FY27 (Mar-2027) enabling a return to dividends/higher ROCE toward pre-COVID levels.
  • Ormax/FICCI CY2026 box office: trend implies >Rs 15,000 cr full-year (record) if H2 holds.
Key risks
  • Content dependence: no Rs 500 cr+ film in H1 CY26; a weak Diwali/H2 slate would stall admissions (FY26 Q4 admissions grew only 1.5% - growth was mostly pricing).
  • Advertising recovery lagging: FY26 ad revenue Rs 464 cr (+3.6%) is still below pre-COVID and management said brands need 'more proof of concept'; ad is the highest-margin line.
  • Regulatory/licensing delays bunch screen openings, and state-level ticket-price caps (Karnataka/Tamil Nadu precedents) or OTT window compression could hit ATP; interest coverage is still flagged 'low' by screener and ROE is only ~5%.
Sources: · fundamentals Tijori Finance (company filings), pulled locally via MCP batch; not licensed for redistribution · prices Yahoo Finance chart API (unlicensed reference data; not for redistribution).